{"nct_id":"NCT02467270","title":"Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2015-06-30","start_date_type":"ACTUAL","primary_completion_date":"2020-04-14","primary_completion_date_type":"ACTUAL","completion_date":"2025-04-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}